Viz.ai to use recruiting platform for pulmonary embolism trial

2021 03 02 17 14 5807 Pulmonary Embolism Illustration 400

Artificial intelligence (AI) software developer Viz.ai will use its Viz Recruit platform to help enroll patients in the National Institute of Health-funded Pulmonary Embolism-Thrombus Removal with Catheter-Directed Thrombolysis (PE-TRACT) clinical trial.

The trial will explore the efficacy of catheter-directed therapy for patients at intermediate risk of PE compared with the use of anticoagulants alone and will enroll 500 patients across 30 to 50 sites, according to the firm.

Page 1 of 363
Next Page